HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,072,643 | +15.4% | 368,394 | +9.0% | 0.08% | +17.4% |
| Q2 2023 | $12,191,722 | +8.6% | 338,002 | +21.0% | 0.07% | +6.2% |
| Q4 2021 | $11,229,000 | -2.5% | 279,263 | -1.4% | 0.06% | -12.2% |
| Q3 2021 | $11,520,000 | -17.6% | 283,184 | -8.0% | 0.07% | -18.7% |
| Q2 2021 | $13,979,000 | -11.6% | 307,833 | -18.9% | 0.09% | -18.0% |
| Q1 2021 | $15,818,000 | -0.7% | 379,411 | +1.7% | 0.11% | -24.5% |
| Q4 2020 | $15,927,000 | +65.9% | 372,917 | +2.1% | 0.15% | +20.5% |
| Q3 2020 | $9,599,000 | -10.4% | 365,271 | -8.5% | 0.12% | -12.9% |
| Q2 2020 | $10,708,000 | +61.2% | 399,406 | +8.2% | 0.14% | +25.0% |
| Q1 2020 | $6,642,000 | – | 369,199 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |